"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!
June 23, 2023
Warning signs from the crypt: Aberrant protein glycosylation marks opportunities for early colorectal cancer detection.

Get in touch